Document:

Independent Contractor Agreement

 EXHIBIT 10.9 
 China Media Networks International, Inc. 
 Independent Contractor Agreement 
  

	 Parties: 
	 China Media Networks International, Inc. (CMNI) 

  

	 	 FP Associates (FP) 

	 	 61 Mill Pond 

	 	 North Andover, MA 01845 

  

	 Arrangement: 
	 FP will act as an independent contractor to CMNI and its subsidiaries. FP’s work
shall consist of managing and directing the sales and marketing organization as well as identifying and evaluating potential strategic acquisitions for CMNI and its subsidiaries, assisting with due diligence, assisting with deal structuring analysis
and negotiations with potential acquisition targets, and assisting CMNI and its subsidiaries in obtaining additional financing. 

  

	 	 The parties agree that there is no minimum amount of work FP is required to provide CMNI
and its subsidiaries under this Agreement. 

  

	 	 FP will provide a monthly update to the CEO of CMNI of its activities and progress.

  

	 Compensation: 
	 CMNI shall pay FP a monthly fee for its services equal to $10,000.00 for so long as this
Agreement shall remain in effect. 

  

	 	 Upon signing this Agreement, a warrant (the Warrant) exercisable for an aggregate of
300,000 shares of CMNI common stock (the Warrant Shares) at the exercise price of $.01 will be issued to FP. The Warrant and the Warrant Shares will be locked up for a period of one year (the Lock-Up Period). During this period, FP shall not,
directly of indirectly, (a) sell, transfer, assign, offer, pledge, contract to sell, transfer or assign, grant any option, right or warrant to purchase, or otherwise transfer, assign or dispose of, directly or indirectly, either privately or
publicly pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended, any of the Warrant or the Warrant Shares (the Locked-Up Securities), or (b) enter into any swap or other arrangement that transfers or assigns to another
person or entity, in whole or in part, any of the economic benefits, obligations or other consequences of any nature of ownership of the Locked-Up Securities, whether any such transaction are to be settled by delivery of the locked-Up Securities in
cash or otherwise. Notwithstanding the restrictions set forth in this agreement, during the Lock-Up Period FP shall be (“PHI”), all other customer information and other information relating to this Agreement. Unless otherwise stated in
writing by CMNI, all information disclosed by CMNI or its subsidiaries to FP shall remain confidential without CMNI or its subsidiaries being obligated to specifically identify, by notice or any other action, any information or material as to which
the protection of this Agreement is desired. 

  

	 	 FP will, after receipt of any Confidential Information, and at all times treat as
confidential all Confidential Information, and will not use the Confidential Information except as expressly set forth herein or otherwise authorized in writing, will implement reasonable procedures to prohibit the disclosure, unauthorized
duplication, misuse or removal of the Confidential Information and will not disclose the Confidential Information to any third party except to (a) those who need to use the Confidential Information in performance of their services for or on
behalf of CMNI or its subsidiaries, or (b) as may otherwise be required pursuant to the order of any law or governmental FP requiring disclosure; provided that FP shall first notify CMNI of such order and afford CMNI the opportunity to seek a
protective order relating to such disclosure. Notwithstanding the above, FP will not be liable to CMNI with regard to any Confidential Information which: 

  

	 	•	 	is now available or becomes available to the public without breach by FP of this Agreement; 

  

	 	•	 	is known by FP at the time of disclosure and is not subject to restriction; 

  

	 	•	 	is developed or learned by FP completely independently of the Confidential Information received by CMNI; 

  

	 	•	 	is lawfully obtained from a third party which has the right to make such disclosure free of any secrecy or confidentiality restrictions; or 

  

	 	•	 	is released for publication or use by CMNI or its subsidiaries in writing. 

  

	 Non-Competition and Non-Solicitation: 
	 For so long as this Agreement remains in effect and for a period of one year after the
termination thereof for any reason, FP will not directly or indirectly (as a consultant, independent contractor or otherwise): 

	 	 permitted to transfer (a) Locked-Up Securities to transferees for estate planning
purposes, so long as any such transferee signs a written instrument satisfactory to CMNI in its sole discretion evidencing such transferee’s agreement to be bound by this agreement with respect to the Lock-Up Securities so transferred, and
(b) commencing 90 days after the registration of the Warrant Shares is declared effective, 25,000 Warrant Shares each month. 

  

	 Account Closing: 
	 When the Injured Workers Pharmacy contract is closed, FP shall be entitled to a 3%
commission on gross revenue generated by CMNI under such contract. Each commission will be paid within 15 days after CMNI is paid in respect of the applicable gross revenue; provided that such commission payments shall terminate upon the termination
of this Agreement, except that any commission payments that were earned while this Agreement remained in effect shall be paid after the termination of this Agreement within the applicable 15-day period referenced above. 

	 Expenses: 
	 CMNI shall reimburse FP for all reasonable and documented out-of-pocket expenses directly
related to its provision of services under this Agreement. 

  

	 Term: 
	 This Agreement shall remain in effect for twelve (12) months, starting on
April 1, 2006, unless sooner terminated as provided below. 

  

	 Termination: 
	 Either party may terminate this Agreement for any reason (or no reason) by providing the
other party with 30 days’ prior written notice. 

  

	 Confidential Information: 
	 For purposes of this Agreement, “Confidential Information” means any information
or compilation of information that is proprietary to CMNI and its subsidiaries and relates to CMNI’s or its subsidiaries’ existing or reasonably foreseeable business, including, but not limited to, any information disclosed by CMNI or its
subsidiaries to FP about their business which is in oral, written, graphic, machine readable or other tangible form and is described, without limitation, as trade secrets, copyright, data documents, proprietary information, software programs,
software source documents, models, inventions, know-how, processes, product, samples, design data, design details and specifications, engineering, financial forecasts, marketing plans, sales technologies, existing or potential customer lists,
protected health information 

  

	 	 (a) engage in consulting to or acting as an independent contractor for businesses, which
engage in the stock and bill of durable medical equipment to hospitals, surgical centers or physicians; 

  

	 	 (b) solicit, entice, induce or encourage any of CMNI’s or its subsidiaries’
customers or suppliers or potential customers to alter their relationship with CMNI or its subsidiaries in any way; or 

  

	 	 (c) solicit, entice, induce or encourage any of CMNI’s or its subsidiaries’
employees, independent contractors, vendors or consultants to alter their relationship with CIVINI or its subsidiaries in any way. 

  

	 Remedies: 
	 In the event of any breach by FP of the provisions relating to “Confidential
Information” and “Non-Competition and Non- Solicitation” above (all such provisions, the Restrictive Covenants), the Warrant, to the extent then unexercised, shall terminate, and any Warrant Shares acquired by FP through the exercise
of the Warrant shall be repurchased by CMNI for their aggregate exercise price. In addition, in the event of any breach or threatened breach of the Restrictive Covenants, CMNI and its subsidiaries shall be entitled, in addition to any then available
legal remedies, to injunctive relief and other equitable remedies to prevent any such breach or threatened breach without having to prove the inadequacy of any then available legal remedies. In the event that any of the Restrictive Covenants are
deemed to be unenforceable by a court of competent jurisdiction by virtue of any or all of their duration, scope or geographic limitation, they shall be limited by such court to whatever reasonable duration, scope or geographic limitation, as the
case may be, such court determines, and thereafter shall be enforceable, as so limited, as if such limited duration, scope or geographic limitation, as the case may be, were originally set forth herein. 

	 Indemnification: 
	 CMNI shall indemnify and hold harmless FP from and against any and all damages, claims and
liabilities it may suffer arising from any and all actions, statements, errors and/or omissions of FP in connection with its performance of its duties under this Agreement, except for any such damages, claims and liabilities arising from its
negligence or willful misconduct in the performance of such duties with respect to which CMNI shall have no indemnification obligations. FP shall indemnify and hold harmless CMNI, its subsidiaries and their respective directors, officer, employees
and agents, from and against any and all damages, claims and liabilities they may suffer arising from the negligence or willful misconduct of FP or its employees and agents in the performance of FP’s duties under this Agreement.

  

	 Waiver: 
	 No waiver of any provision hereof shall be effective unless set forth in a written
agreement signed by all parties hereto. 

  

	 Governing Law: 
	 This Agreement shall be governed by and shall be construed in accordance with the laws of
the Commonwealth of Massachusetts. 

  

	 Amendment: 
	 This Agreement may not be amended or modified except by a written instrument duly executed
on behalf of FP and CMNI. 

 EXECUTED under seal as of April 1, 2006. 
  

			
	FP Associates
		
	By:	 	/s/    illegible        
		
	Name:	 	  
		
	Title:	 	  
	
	China Media Networks International, Inc.
		
	By:	 	/s/    Brian Lesperance        
		
	Name:	 	  
		
	Title:Securities Purchase Agreement

 Exhibit 10.11 
 SECURITIES PURCHASE AGREEMENT 
 THIS SECURITIES PURCHASE AGREEMENT (the
“Agreement”), dated effective the 3rd day of May, 2006, is made by and between VICIS CAPITAL MASTER FUND (the “Purchaser”), and CHINA MEDIA NETWORKS INTERNATIONAL, INC., a Nevada corporation (the
“Company”). 
 Article I 
 SALE OF SECURITIES 
 1.1 Sale of Securities. The Company has authorized the sale to the Purchaser of a
convertible note in the original principal amount of $300,000 (the “Note”), and up to 300,000 shares (the “Shares”) of the Company’s common stock (the “Common Stock”). The Note and the Shares are referred to herein
collectively as the “Securities.” 
 1.2 Purchase Price. Subject to the terms and conditions hereof and on the basis of the
representations and warranties hereinafter set forth, the Company hereby agrees to issue and sell to the Purchaser, and the Purchaser agrees to purchase from the Company, at the Closing (as defined in Section 1.3 hereof), the Securities. This
offer is only being made to the Purchaser as an “accredited investor” (as defined in Rule 501 under the Securities Act of 1933, as amended (the “Securities Act”)) in reliance upon an exemption from registration under
Section 4(2) of the Securities Act and/or Regulation D promulgated thereunder, and on similar exemptions under applicable state laws. 
 1.3 Closing. The closing of the transactions contemplated hereunder (the “Closing”) shall be deemed to occur at the offices of Bingham McCutchen LLP, 150 Federal Street, Boston, MA 02110, or at such other place as shall be
mutually agreeable to the parties, at 5:00 p.m., Boston Time, on May 3, 2006 or such other date as be mutually agreeable to the parties (the “Closing Date”). 
 1.4 Closing Matters. At the Closing the following actions shall be taken: 
 (a) The Purchaser shall deliver $300,000 (the “Purchase Price”) to the Company in immediately available United States funds; and 
 (b) The Company shall deliver the Securities to the Purchaser. 
 (c) The Purchaser acknowledges and agrees that the Purchase Price will be deposited in an account maintained by the Company and that there is no escrow of funds and all funds may be utilized by the Company upon
acceptance. There is no “minimum” sale amount and funds may be released to the Company and closings held, from time to time, as determined by the Company. 
 (d) The Company intends to use the proceeds derived from this sale to satisfy its working capital requirements. Management reserves the right to utilize the net proceeds of the sale in a manner in the best interests
of the Company. The amount of the net proceeds that will be invested in particular areas of the Company’s business will depend upon future economic conditions and business opportunities. To the extent that the Company continues to incur 

 
losses from operations, such losses will be funded from its general funds, including the net proceeds of this sale. 
 1.5 Convertible Debt Financing. (a) The Purchaser acknowledges and understands the Company intends to consummate a subsequent financing of
convertible senior secured debentures and warrants for an aggregate sales price of not less than $1,500,000 (which amount includes the $300,000 Purchase Price received by the Company in exchange for the Securities being sold hereunder) (such
financing, the “Convertible Debt Financing”). The Purchaser further acknowledges and understands that upon the consummation of the Convertible Debt Financing, the Note issued pursuant to this Agreement will be converted into the securities
issuable in such Convertible Debt Financing. Annexed hereto as Exhibit A is a term sheet summarizing the principal terms and conditions relating to the Convertible Debt Financing, and each Purchaser is strongly encouraged to read and
understand such terms prior to making its investment in the Company. 
 (b) The Company further agrees that the Purchaser shall be entitled
to have the Shares issued hereunder registered on the registration statement contemplated by the Convertible Debt Financing, pari passu, with the investors in the Convertible Debt Financing. The foregoing rights, however are subject to each
Purchaser, however, agreeing to the terms and conditions pertaining to such registration as may be set forth in the registration rights agreement or other applicable agreement entered into by the Company and the investors in the Convertible Debt
Financing. 
 Article II 
 REPRESENTATIONS AND WARRANTIES OF COMPANY 
 The Company hereby represents and warrants to the Purchaser as of the
date of this Agreement as follows: 
 (A) The Company owns, directly or indirectly, all of the capital stock of each material subsidiary of
the Company (a “Subsidiary”) free and clear of any and all liens, other than restrictions on transfer under applicable securities laws, and all the issued and outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights. The Company and Subsidiary is duly organized, validly existing and in good standing under the laws of its state of incorporation, with all requisite power and authority to
own, lease, license, and use its properties and assets and to carry out the business in which it is engaged, except where the failure to have or be any of the foregoing may not be expected to have a material adverse effect on the Company’s
presently conducted businesses. Neither the Company nor any Subsidiary is in violation of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company and each
Subsidiary is duly qualified to transact the business in which it is engaged and is in good standing as a foreign corporation in every jurisdiction in which its ownership, leasing, licensing or use of property or assets or the conduct of its
business make such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not, individually or in the aggregate, have or reasonably be expected to result in (i) a material and adverse
effect on the legality, validity or enforceability of this Agreement or the Note, (ii) a material and adverse effect on the results of operations, assets, prospects, business or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole, or (iii) an adverse impairment to the Company’s ability to 

  

 2 

 
perform on a timely basis its obligations hereunder (any of (i), (ii) or (iii), a “Material Adverse Effect”). 
 (B) The Company is authorized to issue 50,000,000 shares of Common Stock, $.0001 par value per share, and no shares of Preferred Stock, $.001 par value
per share. Except as set forth in the Company’s existing Investor Rights Agreement dated as of December 30, 2005, no securities of the Company are entitled to preemptive or similar rights, and no entity or person has any right of first
refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by this Agreement unless any such rights have been waived. Except as a result of the purchase and sale of the Securities, except
as disclosed in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2005, and except in connection with the consummation of the Company’s reverse merger transaction consummated on December 30, 2005,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exchangeable for, or giving any entity or person
any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock, or securities or
rights convertible or exchangeable into shares of Common Stock. The issue and sale of the Securities will not (except pursuant to their terms thereunder), immediately or with the passage of time, obligate the Company to issue shares of Common Stock
or other securities to any entity or person and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under such securities. 
 (C) The Company has the requisite corporate power and authority to enter into, deliver and consummate the transactions contemplated by this Agreement, to
issue, sell and deliver the Securities, and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement and the consummation by it of the transactions contemplated thereby have been duly authorized by the Company
and no further action is required by the Company in connection therewith. When executed and delivered by the Company, this Agreement will constitute the legal, valid and binding obligation of the Company, enforceable as to the Company in accordance
with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, arrangement, fraudulent conveyance or transfer, moratorium or other laws or court decisions, now or hereinafter in effect, relating to or affecting the
rights of creditors generally and as may be limited by general principles of equity and the discretion of the court having jurisdiction in an enforcement action (regardless of whether such enforceability is considered in a proceeding in equity or at
law). 
 (D) No consent, authorization, approval, order, license, certificate or permit of or from, or declaration or filing with, any
federal, state, local or other governmental authority or any court or any other tribunal is required by the Company for the execution, delivery or performance by the Company of this Agreement or the execution, issuance, sale or delivery of the
Securities. 
 (E) Neither the Company nor any Subsidiary is required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other person or entity in connection with the execution, delivery and performance by the Company of this Agreement or the
issuance, sale or delivery of the Securities other than (i) any filings required by state securities laws, (ii) the filing of a Notice of a Sale of Securities on Form D with the 
  

 3 

 
Commission under Regulation D of the Securities Act (iii) those that have been made or obtained prior to or contemporaneously with the date of this
Agreement. 
 (F) The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or
(ii) violate, conflict with, or constitute a default or breach (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any
property or asset of the Company or any Subsidiary is bound or affected, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the
Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
 (G) The Securities
have been duly authorized and, when issued and paid for in accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable, will not be issued in violation of any preemptive or other rights of stockholders, and will be
issued free and clear of all liens and encumbrances, other than restrictions on transfer under applicable securities laws. The Company has reserved from its duly authorized capital stock all of the Shares. 
 (H) Since December 30, 2005, the Company has filed all reports required to be filed by it under the Securities Act of 1933, as amended (the
“Securities Act”), and the Exchange Act of 1934, as amended (the “Exchange Act”), including pursuant to Section 13(a) or 15(d) thereof, for the period from December 30, 2005 and ending as of the date hereof (or such
shorter period as the Company was required by law to file such reports) (the foregoing materials filed during such period being collectively referred to herein as the “SEC Reports”) on a timely basis or has timely filed a valid extension
of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act
and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles in the United States
applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. 

 

 4 

 Article III 
 REPRESENTATIONS AND WARRANTIES OF PURCHASER 
 By signing this Agreement, the Purchaser hereby
represents and warrants to the Company as follows as an inducement to the Company to accept the subscription of the Purchaser: 
 (A) The
Purchaser acknowledges and agrees that (i) the offering and sale of the Securities are intended to be exempt from registration under the Securities Act by virtue of Section 4(2) of the Securities Act and/or Regulation D promulgated
thereunder, (ii) the Securities have not been registered under the Securities Act and (iii) that the Company has represented to the Purchaser (assuming the veracity of the representations of the Purchaser made herein) that the Securities
have been offered and sold by the Company in reliance upon an exemption from registration provided in Section 4(2) of the Securities Act and Regulation D thereunder. In accordance therewith and in furtherance thereof, the Purchaser represents
and warrants to and agrees with the Company that it is an accredited investor (as defined in Rule 501 promulgated under the Securities Act). 
 (B) The Purchaser hereby represents and warrants that the Purchaser is acquiring the Securities hereunder for its own account for investment and not with a view to distribution, and with no present intention of distributing the Securities
or selling the Securities for distribution. The Purchaser understands that the Securities are being sold to the Purchaser in a transaction which is exempt from the registration requirements of the Securities Act. Accordingly, the Purchaser
acknowledges that it has been advised that the Securities have not been registered under the Securities Act and are being sold by the Company in reliance upon the veracity of the Purchaser’s representations contained herein and upon the
exemption from the registration requirements provided by the Securities Act and the securities laws of all applicable states. The Purchaser’s acquisition of the Securities shall constitute a confirmation of the foregoing representation and
warranty and understanding thereof. 
 (C) The Purchaser has such knowledge and experience in financial and business matters as is required
for evaluating the merits and risks of making this investment, and the Purchaser has received such information requested by the Purchaser concerning the business, management and financial affairs of the Company in order to evaluate the merits and
risks of making this investment. Further, the Purchaser acknowledges that the Purchaser has had the opportunity to ask questions of, and receive answers from, the officers of the Company concerning the terms and conditions of this investment and to
obtain information relating to the organization, operation and business of the Company and of the Company’s contracts, agreements and obligations or needed to verify the accuracy of any information contained herein or any other information
about the Company. Except as set forth in this Agreement, no representation or warranty is made by the Company to induce the Purchaser to make this investment, and any representation or warranty not made herein or therein is specifically disclaimed
and no information furnished to the Purchaser or the Purchaser’s advisor(s) in connection with the sale were in any way inconsistent with the information stated herein. The Purchaser further understands and acknowledges that no person has been
authorized by the Company to make any representations or warranties concerning the Company, including as to the accuracy or completeness of the information contained in this Agreement. 
 (D) The Purchaser is making the foregoing representations and warranties with the intent that they may be relied upon by the Company in determining the
suitability of the sale of 
  

 5 

 
the Securities to the Purchaser for purposes of federal and state securities laws. Accordingly, the Purchaser represents and warrants that the information
stated herein is true, accurate and complete, and agrees to notify and supply corrective information promptly to the Company as provided above if any of such information becomes inaccurate or incomplete. The Purchaser has completed this Agreement,
has delivered it herewith and represents and warrants that it is accurate and true in all respects and that it accurately and completely sets forth the financial condition of the Purchaser on the date hereof. The Purchaser has no reason to expect
there will be any material adverse change in its financial condition and will advise the Company of any such changes occurring prior to the Closing. 
 (E) The Purchaser is not subscribing for any of the Securities as a result of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine or similar media or
broadcast over television or radio, any seminar or meeting, or any solicitation of a subscription by a person not previously known to the Purchaser in connection with investments in Securities generally. 
 (F) The Purchaser has received certain information regarding the Company, including this Agreement, and other accompanying documents of the Company
receipt of which is hereby acknowledged. The Purchaser has carefully reviewed all information provided to it and has carefully evaluated and understands the risks described therein related to the Company and an investment in the Company, and
understands and has relied only on the information provided to it in writing by the Company relating to this investment. No agent prepared any of the information to be delivered to prospective investors in connection with this transaction. The
Purchaser is advised to conduct its own review of the business, properties and affairs of the Company before subscribing to purchase the Securities. 
 (G) The Purchaser also understands and agrees that, although the Company will use its best efforts to keep the information provided in this Agreement strictly confidential, the Company or its counsel may present this
Agreement and the information provided in answer to it to such parties as they may deem advisable if called upon to establish the availability under any federal or state securities laws of an exemption from registration of the private placement or
if the contents thereof are relevant to any issue in any action, suit or proceeding to which the Company or its affiliates is a party, or by which they are or may be bound or as otherwise required by law or regulatory authority. 
 (H) The individual signing below on behalf of any entity hereby warrants and represents that he/she is authorized to execute this Agreement on behalf of
such entity. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all requisite action, if any, in respect thereof on the part of the Purchaser and no other
proceedings on the part of the Purchaser are necessary to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by the Purchaser and constitutes a valid and binding obligation of the
Purchaser, enforceable against the Purchaser in accordance with its terms (subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and subject, as to enforceability, to general principles of equity
(whether applied in a proceeding in equity or at law)). 
 (I) The purchase of the Securities involves risks which the Purchaser has
evaluated, and the Purchaser is able to bear the economic risk of the purchase of such Securities and the loss of its entire investment. The undersigned is able to bear the substantial economic risk of the 
  

 6 

 
investment for an indefinite period of time, has no need for liquidity in such investment and can afford a complete loss of such investment. The
Purchaser’s overall commitment to investments that are not readily marketable is not, and his acquisition of the Securities will not cause such overall commitment to become, disproportionate to his net worth and the Purchaser has adequate means
of providing for its current needs and contingencies. 
 (J) The Purchaser acknowledges and agrees that there is no “minimum”
offering amount for the Note and that there is no escrow of the funds deposited by the Purchaser for the purchase of the Note. The Purchaser acknowledges and agrees that funds may be immediately released to the Company. 
 (K) In entering into this Agreement and in purchasing the Securities, the Purchaser further acknowledges that: 
 (i) The Company has informed the Purchaser that the Securities have not been offered for sale by means of general advertising or solicitation and the
Purchaser acknowledges that it has either a pre-existing personal or business relationship with either the Company or any of its officers, directors or controlling person, of a nature and duration such as would enable a reasonable prudent investor
to be aware of the character, business acumen, and general business and financial circumstances of the Company and an investment in the Company’s Securities. 
 (ii) Neither the Securities nor any interest therein may be resold by the Purchaser in the absence of a registration under the Securities Act or an exemption from registration. In particular, the Purchaser is aware
that all of the foregoing described Securities will be “restricted securities”, as such term is defined in Rule 144 promulgated under the Securities Act (“Rule 144”), and they may not be sold pursuant to Rule 144, unless the
conditions thereof are met. Other than set forth in this Agreement, the Company has no obligation to register any securities purchased or issuable hereunder. 
 (iii) The following legends (or similar language) shall be placed on the certificate(s) or other instruments evidencing the Securities: 
 THE SECURITIES REPRESENTED BY THIS [PROMISSORY NOTE] [CERTIFICATE] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER SUCH SECURITIES NOR ANY
INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) THE COMPANY RECEIVES AN
OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS. 
 (iv) The Company may at any time place a stop transfer order on
its transfer books against the Securities. Such stop order will be removed, and further transfer of the 

  

 7 

 
Securities will be permitted, upon an effective registration of the respective Securities, or the receipt by the Company of an opinion of counsel
satisfactory to the Company that such further transfer may be effected pursuant to an applicable exemption from registration. 
 Article IV

 INDEMNIFICATION 
 4.1 Indemnification by the Company. The Company agrees to defend, indemnify and hold harmless the Purchaser and shall reimburse the Purchaser for, from and against each claim, loss, liability, cost and expense (including
without limitation, interest, penalties, costs of preparation and investigation, and the reasonable fees, disbursements and expenses of attorneys, accountants and other professional advisors) (collectively, “Losses”) directly or indirectly
relating to, resulting from or arising out of any untrue representation, misrepresentation, breach of warranty or non-fulfillment of any covenant, agreement or other obligation by or of the Company contained herein or in any certificate, document,
or instrument delivered to the Purchaser pursuant hereto. 
 4.2 Indemnification by the Purchaser. The Purchaser agrees to defend,
indemnify and hold harmless the Company and shall reimburse The Company for, from and against all Losses directly or indirectly relating to, resulting from or arising out of any untrue representation, misrepresentation, breach of warranty or
non-fulfillment of any covenant, agreement or other obligation of the Purchaser contained herein or in any certificate, document or instrument delivered to the Company pursuant hereto. 
 4.3 Procedure. The indemnified party shall promptly notify the indemnifying party of any claim, demand, action or proceeding for which
indemnification will be sought under Sections 4.1 or 4.2 of this Agreement, and, if such claim, demand, action or proceeding is a third party claim, demand, action or proceeding, the indemnifying party will have the right at its expense to assume
the defense thereof using counsel reasonably acceptable to the indemnified party. The indemnified party shall have the right to participate, at its own expense, with respect to any such third party claim, demand, action or proceeding. In connection
with any such third party claim, demand, action or proceeding, the Purchaser and the Company shall cooperate with each other and provide each other with access to relevant books and records in their possession. No such third party claim, demand,
action or proceeding shall be settled without the prior written consent of the indemnified party, which shall not be unreasonably withheld. If a firm written offer is made to settle any such third party claim, demand, action or proceeding and the
indemnifying party proposes to accept such settlement and the indemnified party refuses to consent to such settlement, then: (i) the indemnifying party shall be excused from, and the indemnified party shall be solely responsible for, all
further defense of such third party claim, demand, action or proceeding; and (ii) the maximum liability of the indemnifying party relating to such third party claim, demand, action or proceeding shall be the amount of the proposed settlement if
the amount thereafter recovered from the indemnified party on such third party claim, demand, action or proceeding is greater than the amount of the proposed settlement. 
 ARTICLE V 
 MISCELLANEOUS 
 5.1 Survival. The representations and warranties set forth in Articles II and III 

  

 8 

 
hereof shall survive the Closing. No investigation made by or on behalf of either party shall affect the representations and warranties made pursuant to this
Agreement. No party makes any additional or implied representations other than those set forth herein. 
 5.2 Expenses. Each
party hereto shall bear and pay all costs and expenses incurred by it in connection with the transactions contemplated hereby, including fees and expenses of its own brokers, finders, financial consultants, accountants and counsel. 
 5.3 Entire Agreement. This Agreement, including the Exhibits, contains the entire agreement and understanding of the parties with respect to its
subject matter. This Agreement supersedes all prior arrangements and understandings between the parties, either written or oral, with respect to its subject matter. 
 5.4 Binding Effect of Subscription. The Purchaser hereby acknowledges and agrees, subject to any applicable state securities laws that the subscription and application hereunder are irrevocable, that the
Purchaser is not entitled to cancel, terminate or revoke this Agreement and that this Agreement shall be binding upon and inure to the benefit of the Purchaser and its successors and assigns. 
 5.5 Captions. The table of contents and captions contained in this Agreement are for reference purposes only and are not part of this Agreement.

 5.6 No Waiver. Neither this Agreement nor any provisions hereof shall be waived, modified, discharged, or terminated except by an
instrument in writing signed by the party against whom any such waiver, modification, discharge, or termination is sought. 
 5.7
Notices. Any notice, demand or other communication which any party hereto may be required, or may elect, to give to anyone interested hereunder shall be sufficiently given if (a) deposited, postage prepaid, in a United States mail box,
stamped, registered or certified mail, return receipt requested, addressed to such address as may be listed on the books of the Company, or, if to the Company, the Company’s executive office, or (b) delivered personally at such address.

 5.8 Execution. This Agreement may be executed through the use of separate signature pages or in any number of counterparts, and
each of such counterparts shall, or all purposes, constitute one agreement binding on all parties, notwithstanding that all parties are not signatories to the same counterpart. 
 5.9 Severability. Each provision of this Agreement is intended to be severable from every other provisions, and the invalidity or illegality of
any portion hereof, shall not affect the validity or legality of the remainder hereof. 
 5.10 Non-Assignment. This Agreement is not
transferable or assignable by the Purchaser except as may be provided herein. 
 5.11 Governing Law. All questions concerning the
construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the Commonwealth of Massachusetts, without regard to the principles of conflicts of law
thereof. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any 
  

 9 

 
proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. If either party shall commence a proceeding to enforce any
provisions of this Agreement, then the prevailing party in such proceeding shall be reimbursed by the other party for its reasonable attorney’s fees and other reasonable costs and expenses incurred with the investigation, preparation and
prosecution of such proceeding. 
 5.12 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the
Company, the Purchaser and their respective successors and permitted assigns. 
 Signature page to Securities Purchase Agreement Follows

  

 10 

 SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT 
 IN WITNESS WHEREOF, the parties hereto have executed or caused this Agreement to be executed by their signature as natural persons or by individuals by
their duly authorized officers as of the date first written above. 
 THE COMPANY: 
 CHINA MEDIA NETWORKS INTERNATIONAL, INC.: 
 /s Brian
Lesperance                                     
 By: Brian Lesperance 
 Chief Executive Officer 
 PURCHASER: 
 VICIS CAPITAL MASTER FUND 
 By: Vicis Capital, LLC 
 By: /s/ Shad
Stasney                                     
 Name: Shad Stasney 
 Title: Member 
  

	Address	of Purchaser c/o Vicis Capital, LLC 

 126 E. 56th Street, 7th Floor 
 New York, NY 10022 
 Attn: Shad Stastney 
 The Purchaser is an Accredited Investor because the Purchaser is (check appropriate item): 
  

	 	•	 	an organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, Massachusetts or similar business trust, or partnership, not formed for the specific
purpose of acquiring the Note offered, with total assets in excess of $5,000,000; 

  

	 	•	 	a natural person whose individual net worth or joint net worth with that person’s spouse, at the time of his purchase exceeds $l,000,000; 

  

	 	•	 	a natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each
of those years and has a reasonable expectation of reaching the same income level in the current year; 

  

	 	•	 	a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Note offered, whose purchase is directed by a sophisticated person as
described in Rule 506(b)(2)(ii) of the Securities Act; 

	 	•	 	an entity in which all of the equity owners are accredited investors. (If this alternative is checked, the Purchaser must identify each equity owner and provide statements signed by
each demonstrating how each qualifies as an accredited investor); or 

  

	 	•	 	a director or officer of the Company. 

  

 2 

 EXHIBIT A 
 Term Sheet for Convertible Debt Financing 

 EXHIBIT B 
 Form of Note

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]